Antitumor activity of the novel human breast cancer growth inhibitor, mammary-derived growth inhibitor-related gene, MRG

Cancer Research

Volumn 57, Issue 15, 1997, Pages 3084-3091

  Shi, Y Eric ^a,f   Ni, Jian ^b   Xiao, Guowei ^a   Liu, Yiliang E ^a   Fuchs, Alexander ^a   Yu, Guoliang ^b   Su, Jeffery ^b   Cosgrove, John M ^a   Xing, Lily ^b   Zhang, Mei ^b   Li, Jiyou ^c   Aggarwal, Bharat B ^d   Meager, Anthony ^e   Gentz, Reiner ^b  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b GLAXOSMITHKLINE   (United States)

^c PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^d UNIVERSITY OF TEXAS   (United States)

^e NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH INHIBITOR; MAMMARY DERIVED GROWTH INHIBITOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST CARCINOMA; BREAST EPITHELIUM; BREAST HYPERPLASIA; CANCER INHIBITION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; BREAST NEOPLASMS; CARRIER PROTEINS; CELL DIVISION; CLONING, MOLECULAR; FATTY ACID-BINDING PROTEINS; FEMALE; GENES, TUMOR SUPPRESSOR; GROWTH INHIBITORS; HUMANS; IN SITU HYBRIDIZATION; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; SEQUENCE HOMOLOGY, AMINO ACID; TIME FACTORS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR SUPPRESSOR PROTEINS;

EID: 16944366210     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Porter-Jordan, K., and Lippraan, M. E. Overview of the biological markers of breast cancer. Hematol. Oncol. Clin. N. Am., 8: 73-100, 1994.
2. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
3. Wellings, S. R. A hypothesis of the origin of human breast cancer from the terminal ductal lobular unit. Pathol. Res. Pract., 166: 515-535, 1980.
4. Huynh, H. T., Larsson, C., Narod, S., and Pollak, M. Tumor suppressor activity of the gene encoding mammary derived growth inhibitor. Cancer Res., 55: 2225-2230, 1995.
5. Munn, K. S., Walker, R. A., and Varley, J. M. Frequent alterations of chromosome I in ductal carcinoma in situ of the breast. Oncogene, 10: 1653-1657, 1995.
6. Oh, Y., Muller, H. L., Ng, L., and Rosenfeld, R. G. Transforming growth factor-β-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J. Biol. Chem., 270: 13589-13592, 1995.
7. Butta, A., Maclennan, K., Flanders, K. C., Sacks, N. P., Smith, I., McKinna, A., Dowsett, M., Wakefield, L. M., Sporn, M. B., Baum, M., Colletta, A. A. Induction of transforming growth factor β1 in human breast cancer in vivo following tamoxifen treatment. Cancer Res., 52: 4261-4264, 1992.
8. Recchia, F., Sica, G., de-Filippis, S., Discepoli, S., Torchio, P., and Frati, L. Interferon-β, retinoids, and tamoxifen in the treatment of metastatic breast cancer: a Phase II study. J. Interferon Cytokine Res., 15: 605-610, 1995.
9. Budd, G. T., Green, S., Baker, L. H., Hersh, E. P., Weick, J. K., and Osbome, C. K. A Southwest Oncology Group Phase II trial of recombinant tumor necrosis factor in metastalic breast cancer. Cancer (Phila.), 68: 1694-1695, 1991.
10. Bielka, H., Grosse, R., Bohmer, F., Junghahn, I., and Binas, B. Inhibition of proliferation of Ehrlich ascites carcinoma cells is functionally correlated with reduced activity of the cytosol to stimulate protein synthesis. Biomed. Biochim. Acta, 45: 441-445, 1986.
11. Böhmer, F. D., Mieth, M., Reichmann, G., Taube, C., Grosse, R., and Hollenberg, M. D. A polypeptide growth inhibitor isolated from lactating bovine mammary gland (MDGI) is a lipid-carrying protein. J. Cell Biochem., 38: 199-204, 1988.
12. Unterberg, C., Borchers, T., Hojrup, P., Roepstorff, P., Knudsen, J., and Spener, F. Cardiac fatty acid-binding proteins. Isolation and characterization of the mitochondrial fatty acid-binding protein and its structural relationship with the cytosolic isoforms. J. Biol. Chem., 205: 16255-16261, 1990.
13. Brandt, R., Pepperle, M., Otto, A., Kraft, R., Bohmer, F. D., and Grosse, R. A 13-kd protein purified from milk fat globule membranes is closely related to a mammary derived growth inhibitor. Biochemistry, 27: 1420-1425, 1988.
14. Hong, J., Liu, Y. E., Jia, T., Wang, M., Liu, J., Xiao, G., Joseph, B. K., Rosen, C., and Shi, Y. E. Identification of a breast cancer-specific gene, BCSG1, by differential complementary DNA sequencing. Cancer Res., 57: 759-764, 1997.
15. Adams, M. D., Soares, M. B., Kerlavage, A. R., Field, C., and Venter, J. C. Rapid cDNA sequencing (expressed sequence tags) from a directionally cloned human infant brain cDNA library. Nat. Genet., 4: 373-380, 1993.
16. Adams, M. D., Kelley, J. M., Gocayne, J. D., Dubnick, M., Polymeropoulos, M. H., Xiao, H., Merril, C. R., Wu, A., Oide, B., Moreno, R. F., Kerlavage, A. R., McCombie, W. R., and Venter, J. C. Complementary DNA sequencing: expressed sequence tags and human genome project. Science (Washington DC), 252: 1651-1656, 1991.
17. Sager, R., Anisowicz, A., Neveu, M., Liang, P., and Sotiropoulou, G. Identification by differential display of α6 integrin as a candidate tumor suppressor gene. FASEB J., 7: 964-970, 1993.